Robotic Surgeries Expanded to Oral, Pharyngeal Cancers

Doctors at University of Rochester Medical Center were first in upstate New York to incorporate the precision and dexterity of a surgical robot to remove cancerous tumors in the mouth and throat.

New Drug with URMC Roots Improves Mobility for MS Patients

A new treatment for multiple sclerosis (MS) that improves mobility for some patients earned FDA approval in January 2010. Neurologists at the University of Rochester Medical Center have studied the medication dalfampridine (Ampyra) as an MS treatment more than 10 years.

Strong Consult and Transfer Center

Toll-free (800) 499-9298
(585) 275-4999